Cheukfai相关文献与解析，生知库 | 链接生命科学的每一步

Chen, Bingfeng; Wu, Haoming; Fang, Yutong; Huang, Guangsheng; Guo, Cuiping; Chen, Chunfa; He, Lifang; Chen, Zexiao; Hou, Xiangling; Li, Cheukfai; Wu, Jundong

肿瘤

肿瘤免疫

乳腺癌

免疫/内分泌

发表日期：2024

文献求助收藏

Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations

中国人群不同乳腺癌亚型基因组改变谱和PD-L1表达及其相关性

期刊:Cancer Medicine

影响因子:3.1

doi:10.1002/cam4.5314

Li, Kai; Cao, Li; Li, Cheukfai; Wu, Jundong; Chen, Bo; Zhang, Guochun; Li, Xueri; Wen, Lingzhu; Jia, Minghan; Wei, Guangnan; Lin, Jiali; Li, Yingzi; Zhang, Yuchen; Mok, Hsiaopei; Ren, Chongyang; Wang, Yulei; Qi, Xiaofang; Guo, Lijie; Che, Yue; Liao, Ning

Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status

人表皮生长因子受体2高表达、低表达或不表达状态的乳腺肿瘤具有独特的临床和体细胞突变特征

期刊:BMC Medicine

影响因子:8.3

doi:10.1186/s12916-022-02346-9

Zhang, Guochun; Ren, Chongyang; Li, Cheukfai; Wang, Yulei; Chen, Bo; Wen, Lingzhu; Jia, Minghan; Li, Kai; Mok, Hsiaopei; Cao, Li; Chen, Xiaoqing; Lin, Jiali; Wei, Guangnan; Li, Yingzhi; Zhang, Yuchen; Balch, Charles M; Liao, Ning

Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo

KRAS G12C 抑制剂 Adagrasib 在体内和体外可逆转 ABCB1 介导的多药耐药性

期刊:Cell Communication and Signaling

影响因子:8.2

doi:10.1186/s12964-022-00955-8

Yuchen Zhang #, Cheukfai Li #, Chenglai Xia, Keneth Kin Wah To, Zhixing Guo, Chongyang Ren, Lingzhu Wen, Fang Wang, Liwu Fu, Ning Liao

信号转导

发表日期：2022

文献求助收藏

Spectrum of MAP3K1 mutations in breast cancer is luminal subtype-predominant and related to prognosis

乳腺癌中 MAP3K1 突变谱以管腔亚型为主且与预后相关

期刊:Oncology Letters

影响因子:2.5

doi:10.3892/ol.2022.13187

Cheukfai Li, Guochun Zhang, Yulei Wang, Bo Chen, Kai Li, Li Cao, Chongyang Ren, Lingzhu Wen, Minghan Jia, Hsiaopei Mok, Jianguo Lai, Weikai Xiao, Xuerui Li, Ning Liao

YTHDF1 amplification is correlated with worse outcome and lower immune cell infiltrations in breast cancer

YTHDF1扩增与乳腺癌预后不良和免疫细胞浸润减少相关

期刊:Cancer Biomarkers

影响因子:1.9

doi:10.3233/CBM-203103

Li, Cheukfai; Zhang, Chuanzhao; Zhang, Guochun; Chen, Bo; Li, Xuerui; Li, Kai; Ren, Chongyang; Wen, Lingzhu; Liao, Ning

Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours

与匹配的原发性乳腺肿瘤相比，前哨淋巴结转移和多发淋巴结转移的遗传和免疫特征

期刊:EBioMedicine

影响因子:10.8

doi:10.1016/j.ebiom.2021.103542

Chen, Bo; Zhang, Guochun; Lai, Jianguo; Xiao, Weikai; Li, Xuerui; Li, Cheukfai; Mok, Hsiaopei; Li, Kai; Wang, Yulei; Cao, Li; Jia, Minghan; Ren, Chongyang; Wen, Lingzhu; Wei, Guangnan; Lin, Jiali; Li, Yingzi; Zhang, Yuchen; Chen, Xiaoqing; Wu, Xueying; Zhang, Henghui; Li, Min; Liu, Jing; Balch, Charles M; Liao, Ning

PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing

PIK3CA 体细胞突变在浸润性乳腺癌中的表现：通过新一代测序技术检测到白种人和中国人之间存在差异。

期刊:Breast Cancer

影响因子:2.9

doi:10.1007/s12282-020-01199-5

Jia, Minghan; Liao, Ning; Chen, Bo; Zhang, Guochun; Wang, Yulei; Li, Xuerui; Cao, Li; Mok, Hsiaopei; Ren, Chongyang; Li, Kai; Li, Cheukfai; Wen, Lingzhu; Lin, Jiali; Wei, Guangnan; Balch, Charles M

Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients

中国乳腺癌患者AKT体细胞突变的特征分析

期刊:Cancer Management and Research

影响因子:2.6

doi:10.2147/CMAR.S299624

Wen, Lingzhu; Zhang, Guochun; Ren, Chongyang; Li, Xuerui; Mok, Hsiaopei; Jia, Minghan; Wang, Yulei; Chen, Bo; Li, Kai; Cao, Li; Li, Cheukfai; Xiao, Weikai; Lai, Jianguo; Lin, Jiali; Wei, Guangnan; Li, Yingzi; Zhang, Yuchen; Chen, Xiaoqing; Liao, Ning

Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy

中国HER2阳性乳腺癌的基因突变谱及新辅助抗HER2治疗反应的遗传预测因子

期刊:Breast Cancer Research and Treatment

影响因子:3

doi:10.1007/s10549-020-05778-0

Li, Kai; Liao, Ning; Chen, Bo; Zhang, Guochun; Wang, Yulei; Guo, Liping; Wei, Guangnan; Jia, Minghan; Wen, Lingzhu; Ren, Chongyang; Cao, Li; Mok, Hsiaopei; Li, Cheukfai; Lin, Jiali; Chen, Xiaoqing; Zhang, Zhou; Hou, Ting; Li, Min; Liu, Jing; Balch, Charles M; Liao, Ning

Prognostic implication of novel immune-related signature in breast cancer

新型免疫相关特征在乳腺癌预后中的意义

Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations

中国人群不同乳腺癌亚型基因组改变谱和PD-L1表达及其相关性

Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status

人表皮生长因子受体2高表达、低表达或不表达状态的乳腺肿瘤具有独特的临床和体细胞突变特征

Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo

KRAS G12C 抑制剂 Adagrasib 在体内和体外可逆转 ABCB1 介导的多药耐药性

Spectrum of MAP3K1 mutations in breast cancer is luminal subtype-predominant and related to prognosis

乳腺癌中 MAP3K1 突变谱以管腔亚型为主且与预后相关

YTHDF1 amplification is correlated with worse outcome and lower immune cell infiltrations in breast cancer

YTHDF1扩增与乳腺癌预后不良和免疫细胞浸润减少相关

Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours

与匹配的原发性乳腺肿瘤相比，前哨淋巴结转移和多发淋巴结转移的遗传和免疫特征

PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing

PIK3CA 体细胞突变在浸润性乳腺癌中的表现：通过新一代测序技术检测到白种人和中国人之间存在差异。

Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients

中国乳腺癌患者AKT体细胞突变的特征分析

Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy

中国HER2阳性乳腺癌的基因突变谱及新辅助抗HER2治疗反应的遗传预测因子